Safety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia Naive

Stopped early · Phase 1 · Has a placebo group

Conditions studied: HIV Infections, Smallpox

In brief

The purpose of this study is to assess the safety and immunogenicity of two MVA smallpox vaccine injections in healthy adults that are 18-35 years of age with HIV infection

Key facts

Study ID
NCT00282581
Run by
Sanofi Pasteur, a Sanofi Company
People needed
2
Starts
2006-10-01
Expected to finish
2007-07-01
Last updated by the study team
2014-01-22

Who can join

Age: 18 and older, up to 35. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.